Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
21 Oct 2024
Historique:
received: 09 08 2023
accepted: 18 09 2024
medline: 22 10 2024
pubmed: 22 10 2024
entrez: 21 10 2024
Statut: aheadofprint

Résumé

Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus, nucleus accumbens, amygdala and the ventral diencephalon) in 74,898 participants of European ancestry. We identified 254 independent loci associated with these brain volumes, explaining up to 35% of phenotypic variance. We observed gene expression in specific neural cell types across differentiation time points, including genes involved in intracellular signaling and brain aging-related processes. Polygenic scores for brain volumes showed predictive ability when applied to individuals of diverse ancestries. We observed causal genetic effects of brain volumes with Parkinson's disease and attention-deficit/hyperactivity disorder. Findings implicate specific gene expression patterns in brain development and genetic variants in comorbid neuropsychiatric disorders, which could point to a brain substrate and region of action for risk genes implicated in brain diseases.

Identifiants

pubmed: 39433889
doi: 10.1038/s41588-024-01951-z
pii: 10.1038/s41588-024-01951-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

Références

Thompson, P. M. et al. ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl. Psychiatry 10, 1–28 (2020).
doi: 10.1038/s41398-020-0705-1
Satizabal, C. L. et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet. 51, 1624–1636 (2019).
pubmed: 31636452 pmcid: 7055269 doi: 10.1038/s41588-019-0511-y
Xu, H. et al. Subcortical brain abnormalities and clinical relevance in patients with hemifacial spasm. Front. Neurol. 10, 1383 (2019).
pubmed: 32010045 doi: 10.3389/fneur.2019.01383
Van Schouwenburg, M. R., den Ouden, H. E. M. & Cools, R. The human basal ganglia modulate frontal-posterior connectivity during attention shifting. J. Neurosci. 30, 9910–9918 (2010).
pubmed: 20660273 pmcid: 6632831 doi: 10.1523/JNEUROSCI.1111-10.2010
Bickart, K. C., Wright, C. I., Dautoff, R. J., Dickerson, B. C. & Barrett, L. F. Amygdala volume and social network size in humans. Nat. Neurosci. 14, 163–164 (2011).
pubmed: 21186358 doi: 10.1038/nn.2724
Palomero-Gallagher, N. & Amunts, K. A short review on emotion processing: a lateralized network of neuronal networks. Brain Struct. Funct. 227, 673–684 (2021).
pubmed: 34216271 pmcid: 8844151 doi: 10.1007/s00429-021-02331-7
Krabbe, K. et al. Increased intracranial volume in Parkinson’s disease. J. Neurol. Sci. 239, 45–52 (2005).
pubmed: 16225890 doi: 10.1016/j.jns.2005.07.013
Tate, D. F. et al. Intracranial volume and dementia: some evidence in support of the cerebral reserve hypothesis. Brain Res. 1385, 151 (2011).
pubmed: 21172323 doi: 10.1016/j.brainres.2010.12.038
Klein, M. et al. Genetic markers of ADHD-related variations in intracranial volume. Am. J. Psychiatry 176, 228–238 (2019).
pubmed: 30818988 pmcid: 7780894 doi: 10.1176/appi.ajp.2018.18020149
Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091–1102 (2019).
pubmed: 31701892 pmcid: 8422160 doi: 10.1016/S1474-4422(19)30320-5
Sønderby, I. E. et al. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Mol. Psychiatry 25, 584 (2020).
pubmed: 30283035 doi: 10.1038/s41380-018-0118-1
Hibar, D. P. et al. Common genetic variants influence human subcortical brain structures. Nature 520, 224–229 (2015).
pubmed: 25607358 pmcid: 4393366 doi: 10.1038/nature14101
Grasby, K. L. et al. The genetic architecture of the human cerebral cortex. Science 367, eaay6690 (2020).
pubmed: 32193296 pmcid: 7295264 doi: 10.1126/science.aay6690
Nawaz, M. S. et al. Thirty novel sequence variants impacting human intracranial volume. Brain Commun. 4, fcac271 (2022).
pubmed: 36415660 pmcid: 9677475 doi: 10.1093/braincomms/fcac271
Adams, H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci. 19, 1569–1582 (2016).
pubmed: 27694991 pmcid: 5227112 doi: 10.1038/nn.4398
Hibar, D. P. et al. Novel genetic loci associated with hippocampal volume. Nat. Commun. 8, 13624 (2017).
pubmed: 28098162 pmcid: 5253632 doi: 10.1038/ncomms13624
Hofer, E. et al. Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults. Nat. Commun. 11, 4796 (2020).
pubmed: 32963231 pmcid: 7508833 doi: 10.1038/s41467-020-18367-y
Van der Meer, D. & Kaufmann, T. Mapping the genetic architecture of cortical morphology through neuroimaging: progress and perspectives. Transl. Psychiatry 12, 447 (2022).
pubmed: 36241627 pmcid: 9568576 doi: 10.1038/s41398-022-02193-5
Loughnan, R. J. et al. Generalization of cortical MOSTest genome-wide associations within and across samples. Neuroimage 263, 119632 (2022).
pubmed: 36115590 doi: 10.1016/j.neuroimage.2022.119632
Park, S. M., Park, H. R. & Lee, J. H. MAPK3 at the autism-linked human 16p11.2 locus influences precise synaptic target selection at Drosophila larval neuromuscular junctions. Mol. Cells 40, 151 (2017).
pubmed: 28196412 pmcid: 5339506 doi: 10.14348/molcells.2017.2307
Choi, C. Y., Vo, M. T., Nicholas, J. & Choi, Y. B. Autophagy-competent mitochondrial translation elongation factor TUFM inhibits caspase-8-mediated apoptosis. Cell Death Differ. 29, 451–464 (2022).
pubmed: 34511600 doi: 10.1038/s41418-021-00868-y
Lee, S. & Choi, I. Expression patterns and biological function of Specc1 during mouse preimplantation development. Gene Expr. Patterns 41, 119196 (2021).
pubmed: 34166821 doi: 10.1016/j.gep.2021.119196
Kaku, H. & Rothstein, T. L. FAIM is a non-redundant defender of cellular viability in the face of heat and oxidative stress and interferes with accumulation of stress-induced protein aggregates. Front. Mol. Biosci. 7, 32 (2020).
pubmed: 32175331 pmcid: 7056718 doi: 10.3389/fmolb.2020.00032
Redenšek, S., Trošt, M. & Dolžan, V. Genetic determinants of Parkinson’s disease: can they help to stratify the patients based on the underlying molecular defect? Front. Aging Neurosci. 9, 20 (2017).
pubmed: 28239348 pmcid: 5301007 doi: 10.3389/fnagi.2017.00020
Ham, S. et al. Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model. Sci. Rep. 7, 525 (2017).
pubmed: 28366931 pmcid: 5428870 doi: 10.1038/s41598-017-00614-w
Cheng, W.-W., Zhu, Q. & Zhang, H.-Y. Identifying risk genes and interpreting pathogenesis for Parkinson’s disease by a multiomics analysis. Genes 11, 1100 (2020).
pubmed: 32967142 pmcid: 7563773 doi: 10.3390/genes11091100
Inda, C. et al. cAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells. Sci. Rep. 7, 1944 (2017).
pubmed: 28512295 pmcid: 5434020 doi: 10.1038/s41598-017-02021-7
Jerber, J. et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat. Genet. 53, 304–312 (2021).
pubmed: 33664506 pmcid: 7610897 doi: 10.1038/s41588-021-00801-6
Grotzinger, A. D. et al. Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. Nat. Hum. Behav. 3, 513–525 (2019).
pubmed: 30962613 pmcid: 6520146 doi: 10.1038/s41562-019-0566-x
Liu, N. et al. Cross-ancestry genome-wide association meta-analyses of hippocampal and subfield volumes. Nat. Genet. 55, 1126–1137 (2023).
pubmed: 37337106 doi: 10.1038/s41588-023-01425-8
Roshchupkin, G. V. et al. Heritability of the shape of subcortical brain structures in the general population. Nat. Commun. 7, 13738 (2016).
pubmed: 27976715 pmcid: 5172387 doi: 10.1038/ncomms13738
Rentería, M. E. et al. Genetic architecture of subcortical brain regions: common and region-specific genetic contributions. Genes Brain Behav. 13, 821–830 (2014).
pubmed: 25199620 doi: 10.1111/gbb.12177
Smith, S. M. et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat. Neurosci. 24, 737–745 (2021).
pubmed: 33875891 pmcid: 7610742 doi: 10.1038/s41593-021-00826-4
Angeles, F.-G. M., Palacios-Bote, R., Leo-Barahona, M. & Mora-Encinas, J. P. Anatomy of the brainstem: a gaze into the stem of life. Semin. Ultrasound CT MR 31, 196–219 (2010).
doi: 10.1053/j.sult.2010.03.006
Lanciego, J. L., Luquin, N. & Obeso, J. A. Functional neuroanatomy of the basal ganglia. Cold Spring Harb. Perspect. Med. 2, a009621 (2012).
pubmed: 23071379 pmcid: 3543080 doi: 10.1101/cshperspect.a009621
Javed, N. & Cascella, M. Neuroanatomy, Globus Pallidus (StatPearls Publishing, 2023).
Young, C. B., Reddy, V. & Sonne, J. Neuroanatomy, Basal Ganglia (StatPearls Publishing, 2022).
Yang, Y. & Wang, J.-Z. From structure to behavior in basolateral amygdala-hippocampus circuits. Front. Neural Circuits 11, 86 (2017).
pubmed: 29163066 pmcid: 5671506 doi: 10.3389/fncir.2017.00086
Walton, E. et al. Exploration of shared genetic architecture between subcortical brain volumes and anorexia nervosa. Mol. Neurobiol. 56, 5146–5156 (2019).
pubmed: 30519816 doi: 10.1007/s12035-018-1439-4
Schmaal, L. et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol. Psychiatry 21, 806–812 (2015).
pubmed: 26122586 pmcid: 4879183 doi: 10.1038/mp.2015.69
García-Marín, L. M. et al. Large-scale genetic investigation reveals genetic liability to multiple complex traits influencing a higher risk of ADHD. Sci. Rep. 11, 22628 (2021).
pubmed: 34799595 pmcid: 8604995 doi: 10.1038/s41598-021-01517-7
Bivol, S. et al. Australian Parkinson’s Genetics Study (APGS): pilot (n = 1532). BMJ Open 12, e052032 (2022).
pubmed: 35217535 pmcid: 8883215 doi: 10.1136/bmjopen-2021-052032
Hoogman, M. et al. Subcortical brain volume differences of participants with ADHD across the lifespan: an ENIGMA collaboration. Lancet Psychiatry 4, 310 (2017).
pubmed: 28219628 pmcid: 5933934 doi: 10.1016/S2215-0366(17)30049-4
Müller, M. et al. YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins. Sci. Rep. 5, 12523 (2015).
pubmed: 26235900 pmcid: 4522686 doi: 10.1038/srep12523
Zhang, C. et al. Genomic identification and expression analysis of nuclear pore proteins in Malus domestica. Sci. Rep. 10, 17426 (2020).
pubmed: 33060661 pmcid: 7566457 doi: 10.1038/s41598-020-74171-0
Mao, Q. et al. KTN1 variants underlying putamen gray matter volumes and Parkinson’s disease. Front. Neurosci. 14, 651 (2020).
pubmed: 32655362 pmcid: 7324786 doi: 10.3389/fnins.2020.00651
Yao, S. et al. A transcriptome-wide association study identifies susceptibility genes for Parkinson’s disease. NPJ Parkinsons Dis. 7, 79 (2021).
pubmed: 34504106 pmcid: 8429416 doi: 10.1038/s41531-021-00221-7
Xu, J. et al. Effects of urban living environments on mental health in adults. Nat. Med. 29, 1456–1467 (2023).
pubmed: 37322117 pmcid: 10287556 doi: 10.1038/s41591-023-02365-w
Cursano, S. et al. A CRHR1 antagonist prevents synaptic loss and memory deficits in a trauma-induced delirium-like syndrome. Mol. Psychiatry 26, 3778 (2021).
pubmed: 32051550 doi: 10.1038/s41380-020-0659-y
Kim, M. S. et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. Genome Biol. 23, 194 (2022).
pubmed: 36100952 pmcid: 9472407 doi: 10.1186/s13059-022-02766-z
Lamballais, S., Jansen, P. R., Labrecque, J. A., Ikram, M. A. & White, T. Genetic scores for adult subcortical volumes associate with subcortical volumes during infancy and childhood. Hum. Brain Mapp. 42, 1583–1593 (2021).
pubmed: 33528897 pmcid: 7978120 doi: 10.1002/hbm.25292
Wang, Y. et al. Theoretical and empirical quantification of the accuracy of polygenic scores in ancestry divergent populations. Nat. Commun. 11, 3865 (2020).
pubmed: 32737319 pmcid: 7395791 doi: 10.1038/s41467-020-17719-y
Campos, A. I. et al. Boosting the power of genome-wide association studies within and across ancestries by using polygenic scores. Nat. Genet. 55, 1769–1776 (2023).
pubmed: 37723263 doi: 10.1038/s41588-023-01500-0
Aschard, H., Vilhjálmsson, B. J., Joshi, A. D., Price, A. L. & Kraft, P. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am. J. Hum. Genet. 96, 329–339 (2015).
pubmed: 25640676 pmcid: 4320269 doi: 10.1016/j.ajhg.2014.12.021
Voevodskaya, O. et al. The effects of intracranial volume adjustment approaches on multiple regional MRI volumes in healthy aging and Alzheimer’s disease. Front. Aging Neurosci. 6, 264 (2014).
pubmed: 25339897 pmcid: 4188138 doi: 10.3389/fnagi.2014.00264
Unverdi, M. & Alsayouri, K. Neuroanatomy, Cerebellar Dysfunction (StatPearls Publishing, 2023).
Thompson, P. M. et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. 8, 153–182 (2014).
pubmed: 24399358 pmcid: 4008818 doi: 10.1007/s11682-013-9269-5
Psaty, B. M. et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. 2, 73–80 (2009).
pubmed: 20031568 pmcid: 2875693 doi: 10.1161/CIRCGENETICS.108.829747
Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379 pmcid: 4380465 doi: 10.1371/journal.pmed.1001779
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Loh, P.-R. et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat. Genet. 47, 284–290 (2015).
pubmed: 25642633 pmcid: 4342297 doi: 10.1038/ng.3190
Alfaro-Almagro, F. et al. Image processing and quality control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage 166, 400 (2018).
pubmed: 29079522 doi: 10.1016/j.neuroimage.2017.10.034
Volkow, N. D. et al. The conception of the ABCD study: from substance use to a broad NIH collaboration. Dev. Cogn. Neurosci. 32, 4–7 (2018).
pubmed: 29051027 doi: 10.1016/j.dcn.2017.10.002
Hagler, D. J. Jr et al. Image processing and analysis methods for the Adolescent Brain Cognitive Development study. Neuroimage 202, 116091 (2019).
pubmed: 31415884 doi: 10.1016/j.neuroimage.2019.116091
Casey, B. J. et al. The Adolescent Brain Cognitive Development (ABCD) study: imaging acquisition across 21 sites. Dev. Cogn. Neurosci. 32, 43–54 (2018).
pubmed: 29567376 pmcid: 5999559 doi: 10.1016/j.dcn.2018.03.001
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836 doi: 10.1038/ng.3656
Saragosa-Harris, N. M. et al. A practical guide for researchers and reviewers using the ABCD study and other large longitudinal datasets. Dev. Cogn. Neurosci. 55, 101115 (2022).
pubmed: 35636343 pmcid: 9156875 doi: 10.1016/j.dcn.2022.101115
Crowley, S. et al. Considering total intracranial volume and other nuisance variables in brain voxel based morphometry in idiopathic PD. Brain Imaging Behav. 12, 1 (2018).
pubmed: 28070745 pmcid: 5502201 doi: 10.1007/s11682-016-9656-9
Turley, P. et al. Multi-trait analysis of genome-wide association summary statistics using MTAG. Nat. Genet. 50, 229–237 (2018).
pubmed: 29292387 pmcid: 5805593 doi: 10.1038/s41588-017-0009-4
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559 (2007).
pubmed: 17701901 pmcid: 1950838 doi: 10.1086/519795
Fischl, B. FreeSurfer. Neuroimage 62, 774–781 (2012).
pubmed: 22248573 doi: 10.1016/j.neuroimage.2012.01.021
Makris, N. et al. Decreased volume of the brain reward system in alcoholism. Biol. Psychiatry 64, 192–202 (2008).
pubmed: 18374900 pmcid: 2572710 doi: 10.1016/j.biopsych.2008.01.018
De Leeuw, C. A., Mooij, J. M. & Heskes, T. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657 doi: 10.1371/journal.pcbi.1004219
Watanabe, K., Taskesen, E. & van Bochoven, A. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun. 8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698 doi: 10.1038/s41467-017-01261-5
Gusev, A. et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245–252 (2016).
pubmed: 26854917 pmcid: 4767558 doi: 10.1038/ng.3506
Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481–487 (2016).
pubmed: 27019110 doi: 10.1038/ng.3538
O’Brien, H. E. et al. Expression quantitative trait loci in the developing human brain and their enrichment in neuropsychiatric disorders. Genome Biol. 19, 194 (2018).
pubmed: 30419947 pmcid: 6231252 doi: 10.1186/s13059-018-1567-1
Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
García-Marín, L. M., Campos, A. I., Martin, N. G., Cuéllar-Partida, G. & Rentería, M. E. Inference of causal relationships between sleep-related traits and 1,527 phenotypes using genetic data. Sleep 44, zsaa154 (2020).
doi: 10.1093/sleep/zsaa154
Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709–717 (2016).
pubmed: 27182965 pmcid: 5207801 doi: 10.1038/ng.3570
García-Marín, L. M. et al. Shared molecular genetic factors influence subcortical brain morphometry and Parkinson’s disease risk. NPJ Parkinsons Dis. 9, 73 (2023).
pubmed: 37164954 pmcid: 10172359 doi: 10.1038/s41531-023-00515-y
Mitchell, B. L. et al. Elucidating the relationship between migraine risk and brain structure using genetic data. Brain 145, 3214–3224 (2022).
pubmed: 35735024 doi: 10.1093/brain/awac105
Frei, O. et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat. Commun. 10, 2417 (2019).
pubmed: 31160569 pmcid: 6547727 doi: 10.1038/s41467-019-10310-0
O’Connor, L. J. & Price, A. L. Distinguishing genetic correlation from causation across 52 diseases and complex traits. Nat. Genet. 50, 1728 (2018).
pubmed: 30374074 pmcid: 6684375 doi: 10.1038/s41588-018-0255-0
Darrous, L., Mounier, N. & Kutalik, Z. Simultaneous estimation of bi-directional causal effects and heritable confounding from GWAS summary statistics. Nat. Commun. 12, 7274 (2021).
pubmed: 34907193 pmcid: 8671515 doi: 10.1038/s41467-021-26970-w
Aman, A. M. et al. Phenome-wide screening of the putative causal determinants of depression using genetic data. Hum. Mol. Genet. 31, 2887–2898 (2022).
pubmed: 35394011 doi: 10.1093/hmg/ddac081
García-Marín, L. M. et al. Phenome-wide screening of GWAS data reveals the complex causal architecture of obesity. Hum. Genet. 140, 1253–1265 (2021).
pubmed: 34057592 doi: 10.1007/s00439-021-02298-9
García-Marín, L. M., Campos, A. I., Martin, N. G., Cuéllar-Partida, G. & Rentería, M. E. Phenome-wide analysis highlights putative causal relationships between self-reported migraine and other complex traits. J. Headache Pain 22, 66 (2021).
pubmed: 34238214 pmcid: 8268337 doi: 10.1186/s10194-021-01284-w
Lloyd-Jones, L. R. et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun. 10, 5086 (2019).
pubmed: 31704910 pmcid: 6841727 doi: 10.1038/s41467-019-12653-0
Chung, W. Statistical models and computational tools for predicting complex traits and diseases. Genomics Inform. 19, e36 (2021).
pubmed: 35012283 pmcid: 8752975 doi: 10.5808/gi.21053

Auteurs

Luis M García-Marín (LM)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Adrian I Campos (AI)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Institute for Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia.

Santiago Diaz-Torres (S)

School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Jill A Rabinowitz (JA)

Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, USA.

Zuriel Ceja (Z)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Brittany L Mitchell (BL)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Katrina L Grasby (KL)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Jackson G Thorp (JG)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Ingrid Agartz (I)

Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Stockholm, Sweden.

Saud Alhusaini (S)

Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA.
Molecular and Cellular Therapeutics Department, Royal College of Surgeons in Ireland, Dublin, Ireland.

David Ames (D)

Academic Unit Psychiatry of Old Age, University of Melbourne, Melbourne, Victoria, Australia.
National Ageing Research Institute, Parkville, Victoria, Australia.

Philippe Amouyel (P)

Universite Lille, U1167-RID-AGE-LabEx DISTALZ-Risk Factors and Molecular Determinants of Aging Diseases, Lille, France.
Institut National de la Santé et de la Recherche Médicale, Lille, France.
Centre Hospitalier Universitaire de Lille Department of Public Health, Lille, France.
Institut Pasteur de Lille UMR1167, Lille, France.

Ole A Andreassen (OA)

Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
KG Jebsen Centre for Neurodevelopmental Disorders, University of Oslo, Oslo, Norway.

Konstantinos Arfanakis (K)

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Department of Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.

Alejandro Arias-Vasquez (A)

Departments of Psychiatry and Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Nicola J Armstrong (NJ)

Department of Mathematics and Statistics, Curtin University, Perth, Western Australia, Australia.

Lavinia Athanasiu (L)

Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
CoE NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Mark E Bastin (ME)

Centre for Clinical Brain Sciences and Edinburgh Imaging, University of Edinburgh, Edinburgh, UK.

Alexa S Beiser (AS)

Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Framingham Heart Study, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA.

David A Bennett (DA)

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Joshua C Bis (JC)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.

Marco P M Boks (MPM)

Brain Center University Medical Center Utrecht, Utrecht, The Netherlands.

Dorret I Boomsma (DI)

Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU Amsterdam, Amsterdam, The Netherlands.

Henry Brodaty (H)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Rachel M Brouwer (RM)

Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU Amsterdam, Amsterdam, The Netherlands.

Jan K Buitelaar (JK)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Ralph Burkhardt (R)

Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg University, Regensburg, Germany.
LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.

Wiepke Cahn (W)

Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands.
Altrecht Mental Health Institute, Utrecht, The Netherlands.

Vince D Calhoun (VD)

Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS)-Georgia State, Georgia Tech and Emory University, Atlanta, GA, USA.

Owen T Carmichael (OT)

Pennington Biomedical Research Center, Baton Rouge, LA, USA.

Mallar Chakravarty (M)

Cerebral Imaging Centre, Douglas Research Centre, Montreal, Quebec, Canada.
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Qiang Chen (Q)

Lieber Institute for Brain Development, Baltimore, MD, USA.

Christopher R K Ching (CRK)

Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Sven Cichon (S)

Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.
Department of Biomedicine, University of Basel, Basel, Switzerland.
Medical Genetics, Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.

Benedicto Crespo-Facorro (B)

HU Virgen del Rocio, Instituto de Investigacion Biomedica IBIS-CSIC, Universidad de Sevilla, CIBERSAM, Sevilla, Spain.

Fabrice Crivello (F)

CNRS, IMN, UMR 5293, University of Bordeaux, Bordeaux, France.

Anders M Dale (AM)

Center for Multimodal Imaging and Genetics, La Jolla, CA, USA.

George Davey Smith (GD)

MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK.
Population Health Sciences, University of Bristol, Bristol, UK.

Eco J C de Geus (EJC)

Department of Biological Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Philip L De Jager (PL)

Center for Translational and Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center, New York City, NY, USA.

Greig I de Zubicaray (GI)

School of Psychology and Counselling, Queensland University of Technology, Brisbane, Queensland, Australia.

Stéphanie Debette (S)

INSERM U1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
Department of Neurology, Institute of Neurodegenerative Diseases, Bordeaux University Hospital, Bordeaux, France.

Charles DeCarli (C)

Imaging of Dementia and Aging Laboratory, Department of Neurology, University of California, Davis, Sacramento, CA, USA.

Chantal Depondt (C)

Department of Neurology, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.

Sylvane Desrivières (S)

Social, Genetic, and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Srdjan Djurovic (S)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.

Stefan Ehrlich (S)

Translational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.

Susanne Erk (S)

German Center of Mental Health (DZPG), Partner Site Berlin/Potsdam, Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Thomas Espeseth (T)

Department of Psychology, University of Oslo, Oslo, Norway.
Department of Psychology, Oslo New University College, Oslo, Norway.

Guillén Fernández (G)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Irina Filippi (I)

INSERM U1299, Paris Saclay University, Gif-sur-Yvette, France.

Simon E Fisher (SE)

Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Debra A Fleischman (DA)

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA.

Evan Fletcher (E)

Department of Neurology, University of California, Davis, Davis, CA, USA.

Myriam Fornage (M)

Institute of Molecular Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.

Andreas J Forstner (AJ)

Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.
Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

Clyde Francks (C)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
Department of Cognitive Neuroscience, Radboud University Medical Center, Nijmegen, The Netherlands.

Barbara Franke (B)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Tian Ge (T)

Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.

Aaron L Goldman (AL)

Lieber Institute for Brain Development, Baltimore, MD, USA.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Robert C Green (RC)

Department of Medicine (Genetics), Mass General Brigham and Harvard Medical School, Boston, MA, USA.

Oliver Grimm (O)

Central Institute of Mental Health, Mannheim, Germany.
Goethe-University Frankfurt, Frankfurt, Germany.

Nynke A Groenewold (NA)

Department of Psychiatry and Mental Health, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Oliver Gruber (O)

Section for Experimental Psychopathology and Neuroimaging, Department of General Psychiatry, Heidelberg University, Heidelberg, Germany.

Vilmundur Gudnason (V)

Icelandic Heart Association, Kopavogur, Iceland.
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Asta K Håberg (AK)

Department of Neuromedicine and Movement, NTNU Science, Trondheim, Norway.
MiDT National Research Center, Department of Research, St Olavs Hospital, Trondheim, Norway.

Unn K Haukvik (UK)

Norwegian Centre for Mental Health Research (NORMENT), Department of Mental Health and Addiction, University of Oslo, Oslo, Norway.
Centre for Forensic Psychiatry Research, Oslo University Hospital, Oslo, Norway.

Andreas Heinz (A)

German Center of Mental Health (DZPG), Partner Site Berlin/Potsdam, Berlin, Germany.
Centre for Forensic Psychiatry Research, Oslo University Hospital, Oslo, Norway.

Derrek P Hibar (DP)

Product Development, Genentech, Inc., South San Francisco, CA, USA.

Saima Hilal (S)

Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.

Jayandra J Himali (JJ)

Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Framingham Heart Study, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA.
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
Department of Population Health Sciences, UT Health Science Center San Antonio, San Antonio, TX, USA.
Department of Neurology, Boston University School of Medicine, Boston, MA, USA.

Beng-Choon Ho (BC)

Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.

David F Hoehn (DF)

Max Planck Institute of Psychiatry, Munich, Germany.

Pieter J Hoekstra (PJ)

Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Accare Child Study Center, Groningen, The Netherlands.

Edith Hofer (E)

Division of Neurogeriatrics, Department of Neurology, Medical University of Graz, Graz, Austria.
Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

Wolfgang Hoffmann (W)

German Centre for Neurodegenerative Diseases (DZNE)-Site Rostock/Greifswald, Greifswald, Germany.
Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Avram J Holmes (AJ)

Department of Psychiatry, Brain Health Institute, Rutgers University, Piscataway, NJ, USA.

Georg Homuth (G)

Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Norbert Hosten (N)

Department of Radiology, University Clinic Greifswald, Greifswald, Germany.

M Kamran Ikram (MK)

Departments of Epidemiology and Neurology, Erasmus MC, Rotterdam, The Netherlands.

Jonathan C Ipser (JC)

Department of Psychiatry and Mental Health, Neuroscience Institute, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.

Clifford R Jack (CR)

Department of Radiology, Mayo Clinic, Rochester, MN, USA.

Neda Jahanshad (N)

Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Erik G Jönsson (EG)

Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Sciences, Stockholm Region, Stockholm, Sweden.

Rene S Kahn (RS)

Altrecht Mental Health Institute, Utrecht, The Netherlands.

Marieke Klein (M)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.

Maria J Knol (MJ)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Lenore J Launer (LJ)

Intramural Research Program, National Institute on Aging, Baltimore, MD, USA.

Stephen M Lawrie (SM)

Division of Psychiatry, University of Edinburgh, Edinburgh, UK.

Stephanie Le Hellard (SL)

Department of Clinical Science, University of Bergen, Bergen, Norway.

Phil H Lee (PH)

Center for Genomic Medicine, Mass General Brigham, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Stanley Center for Psychiatry, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Hervé Lemaître (H)

Groupe d'Imagerie Neurofonctionnelle, Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Université de Bordeaux, Bordeaux, France.

Shuo Li (S)

Department of Biostatistics, School of Public Health, Boston University, Boston, MA, USA.
Framingham Heart Study, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA.

David C M Liewald (DCM)

PPLS, University of Edinburgh, Edinburgh, UK.

Honghuang Lin (H)

Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.

W T Longstreth (WT)

Department of Neurology, University of Washington, Seattle, WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.

Oscar L Lopez (OL)

Departments of Neurology and Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Michelle Luciano (M)

Department of Psychology, University of Edinburgh, Edinburgh, UK.

Pauline Maillard (P)

Department of Neurology, University of California, Davis, Davis, CA, USA.

Andre F Marquand (AF)

Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Nicholas G Martin (NG)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Jean-Luc Martinot (JL)

Université Paris-Saclay, Institut National de la Santé et de la Recherche Médicale, INSERM U1299 'Trajectoires développementales Psychiatrie', Ecole Normale Supérieure Paris-Saclay, CNRS UMR 9010, Université Paris Cité, Centre Borelli, Gif sur Yvette, France.

Karen A Mather (KA)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Venkata S Mattay (VS)

Lieber Institute for Brain Development, Baltimore, MD, USA.

Katie L McMahon (KL)

School of Clinical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia.

Patrizia Mecocci (P)

Institute of Gerontology and Geriatrics, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Clinical Geriatrics, NVS Department, Karolinska Institute, Huddinge, Sweden.

Ingrid Melle (I)

Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Andreas Meyer-Lindenberg (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Nazanin Mirza-Schreiber (N)

Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
Neurogenetic Systems Analysis Group, Institute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.

Yuri Milaneschi (Y)

Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Amsterdam Public Health, Mental Health Program, Amsterdam, The Netherlands.
Amsterdam Neuroscience, Mood, Anxiety, Psychosis, Sleep and Stress Program, Amsterdam, The Netherlands.
Amsterdam Neuroscience, Complex Trait Genetics Program, Amsterdam, The Netherlands.

Thomas H Mosley (TH)

MIND Center, Jackson, MS, USA.

Thomas W Mühleisen (TW)

Institute of Neuroscience and Medicine (INM-1), Research Center Jülich, Jülich, Germany.
Cécile and Oskar Vogt Institute for Brain Research, Medical Faculty, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland.

Bertram Müller-Myhsok (B)

Statistics Genetics Group, Max Planck Institute of Psychiatry, Munich, Germany.

Susana Muñoz Maniega (SM)

Centre for Clinical Brain Sciences and Edinburgh Imaging, University of Edinburgh, Edinburgh, UK.

Matthias Nauck (M)

Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
German Centre for Cardiovascular Research (DZHK), Partner Site Greifswald, Greifswald, Germany.

Kwangsik Nho (K)

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.

Wiro J Niessen (WJ)

University Medical Center Groningen, Groningen, The Netherlands.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany.

Paul A Nyquist (PA)

Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Jaap Oosterlaan (J)

Clinical Neuropsychology Section, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Emma Children's Hospital, University Medical Centers Amsterdam, Amsterdam, The Netherlands.
Amsterdam Reproduction and Development Research Institute, Amsterdam, The Netherlands.

Massimo Pandolfo (M)

Université Libre de Bruxelles, Brussels, Belgium.
Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.

Tomas Paus (T)

Departments of Psychiatry and Neuroscience, Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
Centre Hospitalier Universitaire Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.

Zdenka Pausova (Z)

Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Physiology, University of Toronto, Toronto, Ontario, Canada.

Brenda W J H Penninx (BWJH)

Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

G Bruce Pike (GB)

Departments of Radiology and Clinical Neurosciences, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Bruce M Psaty (BM)

Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
Department of Epidemiology, University of Washington, Seattle, WA, USA.
Department of Health Systems and Population Health, Seattle, WA, USA.

Benno Pütz (B)

Translational Psychiatry, Munich, Germany.

Simone Reppermund (S)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Department of Developmental Disability Neuropsychiatry, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Marcella D Rietschel (MD)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany.

Shannon L Risacher (SL)

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.

Nina Romanczuk-Seiferth (N)

Department of Psychiatry and Neuroscience, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Department of Psychology, Clinical Psychology and Psychotherapy, MSB Medical School Berlin, Berlin, Germany.

Rafael Romero-Garcia (R)

Departamento de Fisiología Médica y Biofísica, Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/Universidad de Sevilla/CIBERSAM, ISCIII, Sevilla, Spain.
Department of Psychiatry, University of Cambridge, Cambridge, UK.

Gennady V Roshchupkin (GV)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Jerome I Rotter (JI)

The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA.

Perminder S Sachdev (PS)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Neuropsychiatric Institute, The Prince of Wales Hospital, Randwick, New South Wales, Australia.

Philipp G Sämann (PG)

Max Planck Institute of Psychiatry, Munich, Germany.

Arvin Saremi (A)

Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Muralidharan Sargurupremraj (M)

INSERM U1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France.
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.

Andrew J Saykin (AJ)

Center for Neuroimaging, Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, USA.
Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.

Lianne Schmaal (L)

Centre for Youth Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Orygen, Parkville, Victoria, Australia.

Helena Schmidt (H)

Institute of Molecular Biology and Biochemistry, Gottfried Schatz Center for Signaling, Metabolism and Aging, Medical University Graz, Graz, Austria.

Reinhold Schmidt (R)

Department of Neurology, Medical University Graz Austria, Graz, Austria.

Peter R Schofield (PR)

Neuroscience Research Australia, Sydney, New South Wales, Australia.
School of Biomedical Sciences, University of New South Wales, Sydney, New South Wales, Australia.

Markus Scholz (M)

LIFE Research Center for Civilization Diseases, University of Leipzig, Leipzig, Germany.
Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.

Gunter Schumann (G)

German Center of Mental Health (DZPG), Partner Site Berlin/Potsdam, Berlin, Germany.
Department of Psychiatry, University of Cambridge, Cambridge, UK.
Centre for Population Neuroscience and Stratified Medicine (PONS), ISTBI, Fudan University, Shanghai, PR China.
PONS Centre, Department of Psychiatry, CCM, Charite Unversitaetsmedizin Berlin, Berlin, Germany.

Emanuel Schwarz (E)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Li Shen (L)

Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Jean Shin (J)

The Hospital for Sick Children, Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.

Albert V Smith (AV)

Icelandic Heart Association, Kopavogur, Iceland.
Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA.

Jordan W Smoller (JW)

Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.

Hilkka S Soininen (HS)

Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.

Vidar M Steen (VM)

Department of Clinical Science, University of Bergen, Bergen, Norway.
Dr. Einar Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Dan J Stein (DJ)

SAMRC Research Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.

Jason L Stein (JL)

Department of Genetics and UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Sophia I Thomopoulos (SI)

Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Arthur W Toga (AW)

Laboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

Diana Tordesillas-Gutiérrez (D)

Instituto de Física de Cantabria (CSIC-UC), Santander, Spain.
Department of Radiology, Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute IDIVAL, Santander, Spain.

Julian N Trollor (JN)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
The National Centre of Excellence in Intellectual Disability Health, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

Maria C Valdes-Hernandez (MC)

Centre for Clinical Brain Sciences and Edinburgh Imaging, University of Edinburgh, Edinburgh, UK.

Dennis van T Ent (D)

Department of Biological Psychology and Netherlands Twin Register, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Hans van Bokhoven (H)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Dennis van der Meer (D)

Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Nic J A van der Wee (NJA)

Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.

Javier Vázquez-Bourgon (J)

Department of Psychiatry, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Departamento de Medicina y Psiquiatría, Universidad de Cantabria, Santander, Spain.
Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM), Sevilla, Spain.

Dick J Veltman (DJ)

Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Meike W Vernooij (MW)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Department of Radiology and Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Arno Villringer (A)

Department of Neurology, Max Planck Institute for Human, Cognitive and Brain Sciences, Leipzig, Germany.
Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Louis N Vinke (LN)

Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Henry Völzke (H)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Joanna M Wardlaw (JM)

Centre for Clinical Brain Sciences and Edinburgh Imaging, University of Edinburgh, Edinburgh, UK.
UK Dementia Research Institute Centre, University of Edinburgh, Edinburgh, UK.

Daniel R Weinberger (DR)

Lieber Institute for Brain Development, Baltimore, MD, USA.
Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.

Michael W Weiner (MW)

University of California, San Francisco, San Francisco, CA, USA.
Northern California Institute for Research and Education (NCIRE), San Francisco, CA, USA.
Veterans Administration Medical Center, San Francisco, CA, USA.

Wei Wen (W)

Centre for Healthy Brain Ageing (CHeBA), Discipline of Psychiatry and Mental Health, School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Lars T Westlye (LT)

Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Eric Westman (E)

Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Huddinge, Sweden.

Tonya White (T)

Section on Social and Cognitive Developmental Neuroscience, National Institute of Mental Health, Bethesda, MD, USA.

A Veronica Witte (AV)

Department of Neurology, Max Planck Institute for Human, Cognitive and Brain Sciences, Leipzig, Germany.
Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Christiane Wolf (C)

Max Planck Institute of Psychiatry, Munich, Germany.

Jingyun Yang (J)

Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.

Marcel P Zwiers (MP)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Sudha Seshadri (S)

Framingham Heart Study, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA.
Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.

Paul M Thompson (PM)

Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Claudia L Satizabal (CL)

Framingham Heart Study, Chobanian and Avedisian Boston University School of Medicine, Boston, MA, USA.
Department of Population Health Sciences and Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, UT Health San Antonio, San Antonio, TX, USA.
Department of Neurology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

Sarah E Medland (SE)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
School of Psychology and Counselling, Queensland University of Technology, Brisbane, Queensland, Australia.
School of Psychology, The University of Queensland, Brisbane, Queensland, Australia.

Miguel E Rentería (ME)

Brain and Mental Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. miguel.renteria@qimrberghofer.edu.au.
School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia. miguel.renteria@qimrberghofer.edu.au.

Classifications MeSH